The Week in Review: July 7 – July 14, 2017

Friday, July 14, 2017 News Recap Local New measures boost addiction treatment access in Victoria New efforts to expand treatment for opioid users in Victoria are putting addiction specialists in hospital emergency departments and supporting family doctors who provide opioid substitution therapy for patients. The initiatives by Island Health and the Victoria Divisions of Family Practice are intended to dovetail with the work of the South Island Ra...

New measures boost addiction treatment access in Victoria

New efforts to expand treatment for opioid users in Victoria are putting addiction specialists in hospital emergency departments and supporting family doctors who provide opioid substitution therapy for patients. The initiatives by Island Health and the Victoria Divisions of Family Practice are intended to dovetail with the work of the South Island Rapid Access Addiction Clinic that opened in the city early this year. The clinic offers streamlined acce

The Week in Review: May 12, 2017 – May 19, 2017

Friday, May 19, 2017 News Recap Canada Help4Hep – BC Helpline Now Online: Did you know that there is now a British Columbia toll-free hepatitis C peer-to-peer helpline where you can get accurate information and meaningful help that is free of charge and confidential?  Check it out now! Help4Hep – BC Helpline Now Online URGENT! Patient and Caregiver Input Request: We Need to Hear your Voice! Patient and Caregiver input is requested by CADTH on Abb...

Hepatitis C Virus Reinfection is Uncommon for Those on Opiate Substitution Therapy after Being Cured with DAAs

Most people on opiate substitution therapy were successfully treated for hepatitis C with an interferon-free regimen of grazoprevir/elbasvir (Zepatier), and only a small number became reinfected during three years of follow-up, researchers reported yesterday at the 25th International Harm Reduction Conference (HR17) in Montréal. Hepatitis C virus (HCV) is easily transmitted through shared drug injection equipment. The advent of new direct-acting antiviral